The 20 Best Diabetic Retinopathy Doctors Near Me in Columbia, MD

Dr. Neil Bressler has been a member of the Wilmer Eye Institute's faculty since 1988 and is the inaugural James P. Gills Professor of Ophthalmology. He specializes in retinal diseases, with special interests in diabetic retinopathy and macular degeneration. Dr. Bressler's main research interests have been collaborative efforts in clinical trials of common retinal diseases, including age-related macular degeneration and diabetic retinopathy, having chaired several NIH-sponsored and industry-sponsored multicenter randomized clinical trials and authored almost 300 peer-reviewed publications. He is a past chair of the NIH-sponsored Diabetic Retinopathy Clinical Research Network, and was responsible for guidelines, policies, protocol development as well as implementation, and to facilitate Network operations in a way that maintains academic integrity and optimal clinical trial performance. He also has chaired the National Eye Institutes Data and Safety Monitoring Committee for intramural clinical trials and the FDA Ophthalmic Devices Panel. Dr. Bressler is currently editor-in-chief of JAMA Ophthalmology. Dr. Bressler is rated as an Elite provider by MediFind in the treatment of Diabetic Retinopathy. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Diabetic Macular Edema (DME), Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Vitrectomy, and Cataract Removal. Dr. Bressler is board certified in American Board Of Ophthalmology.

T. Y. Alvin Liu, M.D. is the James P. Gills, Jr. M.D., and Heather Gills Rising Professor of AI and the founding director of the Wilmer Precision Ophthalmology Center of Excellence. He is originally from Hong Kong, and speaks fluent Cantonese and Mandarin. He attended Phillips Exeter Academy in Exeter, New Hampshire, and graduated from Cornell University with a dual major in biology and economics. He received his M.D. from Columbia University in 2012, and completed his residency (2016) and fellowship (surgical and medical retina- 2018) at Johns Hopkins. He is subspecialty-trained in the medical and surgical treatment of vitreoretinal diseases, including age-related macular degeneration, diabetic retinopathy, diabetic macular edema, retinal vascular occlusion, retinal detachment, vitreous hemorrhage, epiretinal membrane and macular hole. Dr. Liu's research interests center on the application of artificial intelligence in the screening, diagnosis, prognostication and treatment of ophthalmic diseases, with a specific focus on vitreoretinal diseases such as age-related macular degeneration and diabetic retinopathy. In addition, he is involved in research on the pathogenesis of and treatment for pathologic myopia and the management of severe ocular trauma. Videos Dr. Tin Yan Alvin Liu Recent News Articles and Media Coverage AI Speeds Diabetic Retinopathy Diagnosis Without Specialist. Medscape August 28, 2018 AI Screening for Diabetic Retinopathy Moves to Retail Clinics. Medscape November 26, 2019 How Artificial Intelligence is Primed to Change Ophthalmology. Ophthalmology Advisor May 14, 2021 Medicine's first autonomous AI could prevent blindness due to diabetes. Stat News December 16, 2021 Innovations in Eye Care: How Technology is Transforming Ophthalmology. HealthTech November 29, 2022 Time to go multicultural. Retina Today March 1, 2023 How deep learning may play a role in predicting retinitis pigmentosa visual impairment. Ophthalmology Times March 14, 2023 AI in retinal diagnostics. Zhaoke Ophthalmology March 22, 2023 Macular Degeneration. Spotlight on Geographic Atrophy. Advances in Treatment. WebMD April 23, 2023 ARVO 2023: T.Y. Alvin Liu, MD discusses predictive AI and its application in ophthalmology. Modern Retina April 25, 2023 ASCRS: Prediction of imminent conversion to neovascular AMD using deep learning and 3D OCT volumes. OptometryTimes May 5, 2023 Adopting and regulating AI in healthcare. BNN Bloomberg May 29, 2023 AI could increase health equity and boost adherence to annual eye examination in patients with diabetes. Modern Retina June 21, 2023 As more Marylanders grow older, a debilitating eye disease is gaining ground. The Baltimore Banner June 26, 2023. Dr. Liu is rated as an Advanced provider by MediFind in the treatment of Diabetic Retinopathy. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Usher Syndrome Type 2A, Cone-Rod Dystrophy, Doyne Honeycomb Retinal Dystrophy, and Usher Syndrome. Dr. Liu is board certified in American Board Of Ophthalmology.

Anshu Sinha is an Ophthalmologist practicing medicine in Columbia, Maryland. Dr. Sinha is rated as an Experienced provider by MediFind in the treatment of Diabetic Retinopathy. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Glaucoma, Allergic Conjunctivitis, Conjunctivitis (Pink Eye), and Ocular Hypertension (OHT). Dr. Sinha is board certified in American Board Of Ophthalmology.

Dr. Susan Bressler is the Julia G. Levy, Ph.D. Professor of Ophthalmology at the Wilmer Eye Institute. She is an ophthalmologist and has subspecialty training in medical retinal disorders, vitreoretinal disease, and retinal surgery. Her main research interest has been collaborative efforts in clinical trials - serving as principal investigator of an image reading center that has served as a central unit for many clinical trials and epidemiologic investigations, as Vice Chair of the Diabetic Retinopathy Clinical Research Network and as principal investigator of a participating clinical center in several major clinical trials. Most studies have specific emphasis on the treatment of both non-neovascular and neovascular age-related macular degeneration and all aspects of diabetic retinopathy. Dr. Bressler has a large national and international referral practice. In addition, she has published 223 peer reviewed articles and 55 book chapters. Editorial Board positions have included American Journal of Ophthalmology, Survey of Ophthalmology, Retina, EyeNet Magazine, Health After 50: The Johns Hopkins Medical Letter and the Wilmer Retina Update. Dr. Bressler is rated as a Distinguished provider by MediFind in the treatment of Diabetic Retinopathy. She is also highly rated in 14 other conditions, according to our data. Her clinical expertise encompasses Diabetic Macular Edema (DME), Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Diabetic Retinopathy, and Vitrectomy. Dr. Bressler is board certified in American Board Of Ophthalmology.

Peter A. Campochiaro, M.D. is the George S. and Dolores Doré Eccles Professor of Ophthalmology and Neuroscience at the Wilmer Eye Institute, Johns Hopkins University School of Medicine. He is a clinician-scientist who directs a research laboratory and conducts clinical trials. His laboratory research is directed at understanding the pathogenesis of ocular neovascularization and excessive retinal vascular permeability, and the mechanism of cone cell death in inherited retinal degenerations. He helped to determine the importance of vascular endothelial growth factor (VEGF), hypoxia-inducible factor-1, and Tie2 in retinal and choroidal vascular diseases. The clinical trial group under Dr. Campochairo provided the first demonstration of the benefits of suppression of VEGF in diabetic macular edema and retinal vein occlusion. He has developed strategies for sustained suppression of VEGF that are currently being tested in clinical trials. Dr. Campochiaro trained at the University of Notre Dame, Johns Hopkins School of Medicine, and the University of Virginia. He did a vitreoretinal fellowship and research fellowships at Johns Hopkins and joined the faculty of the University of Virginia in 1984. He became professor of Ophthalmology and Neuroscience at the Wilmer Eye Institute, Johns Hopkins in 1991. Dr. Campochiaro is rated as a Distinguished provider by MediFind in the treatment of Diabetic Retinopathy. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Retinal Vein Occlusion, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Trabeculectomy, and Vitrectomy. Dr. Campochiaro is board certified in American Board Of Ophthalmology.

Lenard Hammer is an Ophthalmologist practicing medicine in Columbia, Maryland. Dr. Hammer is rated as an Advanced provider by MediFind in the treatment of Diabetic Retinopathy. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Glaucoma, and Geographic Atrophy.

Malin Howard is an Ophthalmologist practicing medicine in Columbia, Maryland. Dr. Howard is rated as an Experienced provider by MediFind in the treatment of Diabetic Retinopathy. His clinical expertise encompasses Facial Paralysis, Bell's Palsy, Recurrent Peripheral Facial Palsy, and Cataract.

Yassine Daoud is an Ophthalmologist practicing medicine in Columbia, Maryland. Dr. Daoud is rated as an Experienced provider by MediFind in the treatment of Diabetic Retinopathy. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Cataract, Fuchs Dystrophy, Keratoconus, Cataract Removal, and Corneal Transplant.

Shaivi Patel is an Internal Medicine provider practicing medicine in Elkridge, Maryland. Dr. Patel is rated as an Experienced provider by MediFind in the treatment of Diabetic Retinopathy. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Glaucoma, Cataract, Dry Eye Syndrome, and Meibomianitis.

Scott Laborwit is an Ophthalmologist practicing medicine in Elkridge, Maryland. Dr. Laborwit is rated as an Experienced provider by MediFind in the treatment of Diabetic Retinopathy. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Cataract, Presbyopia, Astigmatism, Glaucoma, and Cataract Removal. Dr. Laborwit is board certified in American Board Of Ophthalmology.

"Dr. Shah is an AUPO-fellowship trained ophthalmologist specializing in diseases of the retina, macula, and vitreous. A Pennsylvania native, Dr. Shah attended college at West Chester University of Pennsylvania. He later earned his medical degree at Drexel University College of Medicine and remained there to pursue his residency in Ophthalmology where he was also honored to serve as Chief Resident. Dr. Shah then pursued his fellowship training in vitreoretinal surgery at the Associated Retina Consultants in Phoenix, Arizona. Dr. Shah has been privileged to author or co-author over 40 book chapters and topics as well as publish scientific articles in peer-reviewed journals. He has been invited to lecture both physicians and students on current clinical issues. As a resident, he received multiple honors including Intern of the Year, Resident of the Year, and the Golden Apple for Teaching by the College of Medicine. He was even bestowed with Hahnemann University Hospital's highest award for training physicians – ""Excellence in Clinical Practice for a Fellow, Resident, or Intern."" Dr. Shah enjoys all aspects of retinal disease, but has particular interests in the management of acute, subacute, and chronic retinal disorders including age-related macular degeneration, diabetic retinopathy, and complex retinal detachments. Dr. Shah is a member of the American Society of Retinal Specialists and the American Academy of Ophthalmology.". Dr. Shah is rated as an Advanced provider by MediFind in the treatment of Diabetic Retinopathy. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Orbital Cellulitis, Hyphema, Kallikrein Hypertension, and Optic Nerve Atrophy. Dr. Shah is board certified in American Board Of Ophthalmology.

Fernando Arevalo is an Ophthalmologist practicing medicine in Baltimore, Maryland. Dr. Arevalo is rated as an Advanced provider by MediFind in the treatment of Diabetic Retinopathy. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Gyrate Atrophy of the Choroid and Retina, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, and Diabetic Retinopathy.

Peter L. Gehlbach, M.D., Ph.D. is the J. Willard Marriott, Jr. Professor of Ophthalmology with joint appointment in the Department of Electrical and Computer Engineering, The Whiting School of Engineering. A member of the Wilmer faculty since 2000, he was recruited by a national search to become the inaugural Maumenee Scholar at Johns Hopkins University School of Medicine. His clinical practice is composed of international, national, and regional patient populations with the most complex retinal disease. An expert vitreoretinal surgeon, Dr. Gehlbach has been a leader in performing and teaching complex surgical cases that require coordination with multiple ophthalmological specialists. His research interests include cutting-edge surgical approaches to patients with retinal disease and the development of novel surgical tools and approaches to retinal microsurgery. Dr. Gehlbach’s work has been supported by multiple NIH grants and prestigious foundations with research published in numerous peer-reviewed journals and presented at ophthalmology conferences around the world. The founding director of the former Wilmer Gene Therapy Vector Center, he has served as the director of the Wilmer Echography Center as well as the Retina Fellowship Training Program at Johns Hopkins. He holds multiple patents in both the U.S. and abroad. Dr. Gehlbach received his B.A. and M.D. degrees from the University of Vermont, and his Ph.D. in cell and integrative physiology from the University of Minnesota. He completed an internship and residency training in general surgery at the University of Health Sciences, Chicago Medical School. His ophthalmology residency was at Washington University in St. Louis, where he also completed a fellowship in protein chemistry. He completed a medical and surgical retina fellowship at the Casey Eye Institute in Portland. Dr. Gehlbach is rated as an Advanced provider by MediFind in the treatment of Diabetic Retinopathy. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Retinal Vein Occlusion, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Retinal Detachment, and Vitrectomy. Dr. Gehlbach is board certified in American Board Of Ophthalmology.

Oluwayemisi Adesida is a primary care provider, practicing in Internal Medicine in Laurel, Maryland. Dr. Adesida is rated as an Advanced provider by MediFind in the treatment of Diabetic Retinopathy. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Diabetic Retinopathy, Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, and Hypertension.

Yau Chung is an Ophthalmologist practicing medicine in Laurel, Maryland. Dr. Chung is rated as an Advanced provider by MediFind in the treatment of Diabetic Retinopathy. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Allergic Conjunctivitis, and Interstitial Keratitis.

Yousuf Qureshi is an Ophthalmologist practicing medicine in Laurel, Maryland. Dr. Qureshi is rated as an Advanced provider by MediFind in the treatment of Diabetic Retinopathy. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Interstitial Keratitis, Glaucoma, Ocular Hypertension (OHT), and Cataract.

Scott Maurer is a primary care provider, practicing in Geriatrics in Glenwood, Maryland. Dr. Maurer is rated as an Experienced provider by MediFind in the treatment of Diabetic Retinopathy. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Familial Combined Hyperlipidemia, Xanthoma, Cirrhosis, and High Cholesterol. Dr. Maurer is board certified in American Board Of Internal Medicine.

Shadi Barakat is an Endocrinologist practicing medicine in Baltimore, Maryland. He has been practicing medicine for over 17 years. Dr. Barakat is rated as an Advanced provider by MediFind in the treatment of Diabetic Retinopathy. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Type 2 Diabetes (T2D), Toxic Nodular Goiter, Thyroid Cancer, and Thyroid Storm.

Kristin Flammer is an Endocrinologist practicing medicine in Glen Burnie, Maryland. Dr. Flammer is rated as an Advanced provider by MediFind in the treatment of Diabetic Retinopathy. She is also highly rated in 14 other conditions, according to our data. Her clinical expertise encompasses Type 2 Diabetes (T2D), Thyroid Nodule, Maturity Onset Diabetes of the Young, and Type 1 Diabetes (T1D).

Kathleen Prendergast is an Endocrinologist practicing medicine in Glen Burnie, Maryland. Dr. Prendergast is rated as an Advanced provider by MediFind in the treatment of Diabetic Retinopathy. She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Type 2 Diabetes (T2D), Diabetic Neuropathy, Maturity Onset Diabetes of the Young, and Hypothyroidism.